fda covid vaccine - Search News

News

FDA Names Critic of COVID-19 Shots to Lead Vaccine Agency

Reuters on MSN · 1d

US FDA advisers to discuss COVID-19 vaccine recommendations on May 22

The U.S. Food and Drug Administration said on Wednesday it will hold a meeting of experts on May 22 to discuss COVID-19 vaccine recommendations for the upcoming immunization campaign. The meeting comes after the appointment of Martin Makary as FDA commissioner.

U.S. News & World Report · 23h

FDA Names Critic of COVID-19 Shots to Lead Vaccine Agency: 3 Things to Know

Vinay Prasad, named to lead the FDA agency tasked with regulating vaccines and gene therapy, has made controversial comments regarding the government response to the COVID-19 pandemic.

BioSpace · 22h

FDA Vaccine Advisors To Meet for COVID-19 Vaccine Updates

The independent experts will meet on May 22 to discuss updates to the COVID-19 vaccine for the upcoming season.

19hon MSN

Novavax says talks with FDA on COVID vaccine approval ongoing calming investor fears

Novavax on Thursday tried to calm investors spooked by the delay of full approval of its COVID vaccine shot by U.S.

Knowridge Science Report4h

Combined flu and COVID vaccine shows strong immune response in older people

A new vaccine developed by Moderna aims to protect against both flu and COVID-19 with just one shot. Early studies suggest ...

23hon MSN

RFK Jr. takes aim at COVID shots for kids, worrying vaccine experts

Senior leaders at the FDA began pushing Moderna and Pfizer to file for full, formal approval of their COVID vaccines for ...

1don MSN

Novavax swings to profit, says talks with FDA on COVID vaccine approval ongoing

Novavax said on Thursday discussions with the U.S. health regulator on its COVID-19 shot are ongoing and a pathway to ...

8d

COVID vaccine boosters called into question by FDA chief: ‘Void of data’

Dr. Marty Makary, chief of the FDA, has expressed doubts about the agency approving the COVID-19 vaccine for winter, stating ...

6d

RFK Jr. calls for 'new' vaccines to undergo placebo-controlled trials

A Department of Health and Human Services spokesperson called the move "a radical departure from past practices." ...

Results that may be inaccessible to you are currently showing.

Hide inaccessible results